{
  "hash": "ca4f503c86755d54736ae39c0ac539ed",
  "result": {
    "markdown": "---\ntitle: \"Workpackage 1-Single Drug\"\ndate: \"12/14/2022\"\nformat: \n  html:\n    code-fold: true\n    number-sections: true\nexecute:\n  echo: true\n  warning: false\n  freeze: false\nbibliography: references.bib\ncsl: nature.csl\n---\n\n\n## Workpackage 1A: <br>Quantitative Relationship of Tpos with Numbers of Viable Gram-Negative Bacteria\n\n### Methods\n\nIn this package we will establish the quantitative relationship of Tpos and KPC-carbapenemase producing *Klebsiella pneumoniae* inoculum in blood culture bottles. <br> <br>\n\nThe methods for the assay are a modification of those originally proposed by Kaltsas et al.[@kaltsas2005] Detailed procedures can be found at this [link](Protocols.html). Methodology for preparing the test inoculum was adapted from [CLSI M21A](CLSI_M21A.pdf) and [M26A](CLSI_M26A.pdf) guidelines.[@Clinical_Laboratory_Standards_Institute1999-iy; @Clinical_Laboratory_Standards_Institute1999-iya]\n\n-   Briefly, tubes containing 1.8 mL of pooled healthy human serum are inoculated with 0.2 mL of a series of ten-fold dilutions (5x10^1^ to 5x10^7^ CFU/mL) of the standardised inoculum of each test indicator strains.\n-   The sera were are then transferred into BacT⁄ALERT bottles ***without antibiotic inactivating matrix*** (Biomérieux Inc) for aerobic incubation for 24 hours and monitored for time to positivity.\n-   Tpos results were used to establish preliminary assay quality control ranges by testing in triplicate for five KPC-carbapenemase producing *K. pneumoniae* strains (KPC A, B and C strains; NDM, and VIM producing strains) and a reference *K. pneumoniae* ATCC strain producing ESBL enzyme only. More detailed information on the isolates can be found on the [Protocols](Protocols.html) section.\n-   We also compared how Tpos results change if the organism suspension prepared in phosphate buffered saline (PBS-0.9%) versus pooled human serum (serum).\n\n### Results\n\nThe relationship between Tpos and the *K. pneumoniae* inoculum is shown in [@fig-1] a linear relationship was observed from approximately 10^1^-10^8^ *K. pneumoniae* CFU/mL and a Tpos measured from 10.5 hours-4.5 hours over the tested inoculum range, with R^2^ of 0.92-0.94. The linear relationship of Tpos versus inoculum was consistent if the inoculum was prepared in PBS or pooled human serum as shown in [@tbl-1].\n\n::: callout-note\nIn the paper by Kaltsas et al. [@kaltsas2005] the reported inoculum was the inoculum introduced in to the bloodculture bottle, 30-40 mL of growth media (depending on the manufacturer).\n\nTherefore we have followed this precedent of reporting the inoculum introduced into each bottle. Therefore, this does not represent the final test inoculum that need to account for the total 42 mL volume in each bloodculture bottle.\n\nAll experiments were performed using bloodculture bottles ***without antibiotic inactivating matrix***\n:::\n\n\n::: {.cell}\n\n```{.r .cell-code}\nlibrary (ggplot2)\nlibrary(scales)\ntheme_set(theme_bw())\n## import raw data from .csv file\nwp1 <- read.csv(\"~/Desktop/ACUTEWEBSITE/wp1a.csv\")\n## plot raw data as x-y graph Tpos graph vs. drug concentrations stratified by dilution matrix, method=\"lm\" is the method for linear regression\nfig1 <-ggplot(wp1, aes(x=inoculum, y=tpos, color=isolates, shape=diluent, fill=isolates)) + geom_point(size=4, alpha = 0.5) + \nscale_y_continuous(name=\"Tpos (hr)\", limits=c(4,12)) +\ntheme(legend.text=element_text(size=12)) +\ngeom_smooth(aes(linetype=diluent), method=lm , color=\"black\", fill=\"#69b3a2\", se=TRUE, inherit.aes = TRUE )\nfig1 + theme_bw(base_size = 14)+ scale_x_log10(name=\"Inoculum CFU/mL\", breaks = trans_breaks(\"log10\",n=7, function(x) 10^x),labels = trans_format(\"log10\", math_format(10^.x)))\n```\n\n::: {.cell-output-display}\n![Relationship of time-to-positivity (Tpos) versus test inoculum](Workpackage1_singledrug_files/figure-html/fig-1-1.png){#fig-1 width=672}\n:::\n:::\n\n::: {#tbl-1 .cell tbl-cap='Effect of inoculum diluent on Tpos'}\n\n```{.r .cell-code}\nlibrary(forestmangr)\nlibrary(kableExtra)\nwp1 <- read.csv(\"~/Desktop/ACUTEWEBSITE/wp1a.csv\")\ndf <- data.frame (wp1)\ntable1<-lm_table(df, log(inoculum) ~ tpos, \"diluent\")\nkbl(table1)%>%\nkable_paper(\"hover\", full_width = F, position=\"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\"> diluent </th>\n   <th style=\"text-align:right;\"> b0 </th>\n   <th style=\"text-align:right;\"> b1 </th>\n   <th style=\"text-align:right;\"> Rsqr </th>\n   <th style=\"text-align:right;\"> Rsqr_adj </th>\n   <th style=\"text-align:right;\"> Std.Error </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> pbs </td>\n   <td style=\"text-align:right;\"> 32.05074 </td>\n   <td style=\"text-align:right;\"> -2.564975 </td>\n   <td style=\"text-align:right;\"> 0.9343070 </td>\n   <td style=\"text-align:right;\"> 0.9336227 </td>\n   <td style=\"text-align:right;\"> 1.110872 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> serum </td>\n   <td style=\"text-align:right;\"> 33.02361 </td>\n   <td style=\"text-align:right;\"> -2.840223 </td>\n   <td style=\"text-align:right;\"> 0.9231703 </td>\n   <td style=\"text-align:right;\"> 0.9216023 </td>\n   <td style=\"text-align:right;\"> 1.210130 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n::: callout-note\n## These data confirm that Tpos exhibits a wide dynamic range as a surrogate indicator for viable CFU/mL.\n:::\n\n------------------------------------------------------------------------\n\n## Workpackage 1B: <br> Effect of ceftazidime/avibactam exposure on Tpos\n\n### Ceftazidime-Avibactam\n\nThis workpackage explores how ceftazidime/avibactam concentrations, alone or in combination with other antibiotics, alters Tpos for a standard (1x10^4^ CFU/mL) and high (1x10^7^) inoculum of *Klebsiella pneumoniae*. <br>\n\n### Methods\n\nThe effect of and increasing fixed ceftazidime/avibactam (CAZ/AVI) concentration ratio (4:1) on Tpos was investigated at an inoculum of 1x10^4^ CFU/mL of *K. pneumoniae* KPC_B (MIC 1 mg/L) and *K. pneumoniae* NDM-producing isolate (KPC_NDM; negative control) [@tbl-table2]. All experiments were performed in \\> 5 replicates with an incubation period of 24 hours.\n\nAs shown in [@fig-2], a marked increased in the Tpos for KPC_B from \\< 10 hrs to [\\>]{.underline} 24 hrs when CAZ/AVI concentrations surpassed 1 mg/L. In contrast, the negative control KPC_NDM strain exhibited consistent Tpos \\< 10hr at all test concentrations with lack of antimicrobial activity. Trends in Tpos relative to antibiotic exposure were fitted by Loess.\n\n\n::: {.cell}\n\n```{.r .cell-code}\nlibrary (ggplot2)\ntheme_set(theme_bw())\nceftaz <- read.csv(\"~/Desktop/ACUTEWEBSITE/datasets_single/ceftazidime.csv\")\nggplot(ceftaz, aes(x=conc_s, y=tpos, color=isolate, shape=isolate)) + \n  geom_point(size=4, alpha = 0.7) + \n  geom_smooth(aes(linetype=isolate), method= loess, color=\"black\", fill=\"#69b3a2\", se=TRUE, inherit.aes = TRUE ) +\nscale_x_log10(name=\"CAZ/AVI conc, mg/L\") +\nscale_y_continuous(name=\"Tpos (hr)\", limits=c(4,25)) \n```\n\n::: {.cell-output-display}\n![Effect of ceftazidime/aviactam concentrations on Tpos of K. pneumoniae](Workpackage1_singledrug_files/figure-html/fig-2-1.png){#fig-2 width=672}\n:::\n:::\n\n\n| Isolate                        | Carbapenemase enzyme | Ceftazidime/avibactam Etest MIC (mg/L) |\n|--------------------------------|----------------------|----------------------------------------|\n| *Klebsiella pneumoniae* KPC- B | KPC-3                | 1                                      |\n| *Klebsiella pneumoniae* NDM    | NDM-2                | \\>64                                   |\n\n: Isolates used for testing {#tbl-table2}\n\n##### KPC B isolate (MIC 1 mg/L) tested with commercial pharmaceutical formulation\n\n-   The relationship between ceftazidime/avibactam \"simulated\" serum concentrations and Tpos were analyzed by testing increasing concentrations of ceftazidime (0-8 mg/L) and avibactam (fixed ratio 4:1) using the commercial Avycaz (Zavicefta) formulation in at least 5 replicate experiments performed on separate days.\n-   Bottles were incubated with 1x10^4^ *Klebsiella pneumoniae* KPC_B strain and incubated at 37°C for 24 hours. Tpos positivity was registered using the BACTEC Alert/3D software\n-   Tpos data versus ceftazidime/avibactam concentrations were then fit to a 4-parameter logistic regression model using the Dose-Response Data Analysis (DRDA) package to estimate PD endpoints.[@drda] Regression results were extracted using the Broom [@broom] and Kableextra [@kableExtra] packages.\n-   Results of the pharmacodynamic analysis are shown in [@fig-3]. Ceftazidime/avibactam exhibited a steep Tpos response from and EC~50~ of 83.89 (95% CI 83.06-84.74) to and EC~90~ 95.5 (93.1-97.99). As shown in [@tbl-3], the transitional portion of the dose-response curve occurred 1-dilution above the MIC (1 mg/L) at final concentration in the bottle (2 mg/L) that was determined by Etest.\n\n::: callout-note\nDrug concentrations reported in figures represent the concentration of antibiotic injected (1 mL) into the bottle- \"simulating\" the antibiotic concentrations that would be present in the bloodstream. Hence, these concentrations do not reflect the final antibiotic test concentration per 42 mL. Experiments shown in [@fig-3] were performed using commercial CAZ/AVI pharmaceutical formulation not analytical powder. Concentrations plotted on the X axis indicate simulated serum concentrations of ceftazidime (4:1 relative to avibactam) in tubes.\n:::\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to ceftazidime concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\ncaz_avi_4 <- read_excel(\"datasets_single/kpcb_caz_avi_com.xlsx\")\nfit4 <- drda(tpos ~ ctz_s, data=caz_avi_4, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit4, xlab = \"CAZ/AVI serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to ceftazidime/avibactam concentrations](Workpackage1_singledrug_files/figure-html/fig-3-1.png){#fig-3 width=672}\n:::\n:::\n\n::: {#tbl-3 .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estimates plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\ncaz_avi_4 <- read_excel(\"datasets_single/kpcb_caz_avi_com.xlsx\")\nfit4 <- drda(tpos ~ ctz_s, data=caz_avi_4, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit4, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 73.66731 </td>\n   <td style=\"text-align:right;\"> 71.92413 </td>\n   <td style=\"text-align:right;\"> 75.41048 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 78.61720 </td>\n   <td style=\"text-align:right;\"> 77.51043 </td>\n   <td style=\"text-align:right;\"> 79.72397 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 83.89969 </td>\n   <td style=\"text-align:right;\"> 83.05534 </td>\n   <td style=\"text-align:right;\"> 84.74404 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 89.53712 </td>\n   <td style=\"text-align:right;\"> 88.10788 </td>\n   <td style=\"text-align:right;\"> 90.96636 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 95.55335 </td>\n   <td style=\"text-align:right;\"> 93.12523 </td>\n   <td style=\"text-align:right;\"> 97.98147 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 99.87460 </td>\n   <td style=\"text-align:right;\"> 96.42020 </td>\n   <td style=\"text-align:right;\"> 103.32901 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n<br>\n\n##### KPC B isolate (MIC 1 mg/L) tested with analytical powder\n\n-   The relationship between ceftazidime/avibactam concentrations and Tpos were repeated by testing increasing concentrations of ceftazidime (0-8 mg/L) and avibactam (fixed ratio 4:1) *using the analytical grade powder instead of the commercial pharmaceutical formulation.* Experiments were performed in at least 5 replicate experiments on separate days.\n-   Bottles were incubated with 1x10^4^ *Klebsiella pneumoniae* KPC-B strain and incubated at 37°C for 24 hours. Tpos positivity was registered using the BACTEC Alert/3D software\n-   Tpos data versus ceftazidime/avibactam concentrations were then fit to a 4-parameter logistic regression model using the Dose-Response Data Analysis (DRDA) package to estimate PD endpoints.[@drda] Regression results were extracted using the Broom [@broom] and Kableextra [@kableExtra] packages.\n-   As shown in [@fig-4], ceftazidime/avibactam exhibited a steep Tpos response with increasing concentrations with an EC~50~ of 2.10 (95% CI 2.08-2.12) to and EC~90~ 2.39 (2.33-2.45). The transitional portion of the dose-response curve occurred 1-dilution above the MIC (1 mg/L) determined using Etest strips [@tbl-4].\n\n<br>\n\n::: callout-note\nExperiments shown in [@fig-4] were performed using CAZ/AVI *analytical grade powder* at a fixed 4:1 ratio. Concentrations plotted on the X axis indicate concentrations of ceftazidime (4:1 relative to avibactam) in tubes\n:::\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to ceftazidime concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\ncaz_avi_6 <- read_excel(\"datasets_single/kpcb_caz_avi_powder_4-1.xlsx\")\nfit6 <- drda(tpos ~ ctz_s, data=caz_avi_6, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit6, xlab = \"CAZ/AVI serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to ceftazidime/avibactam concentrations](Workpackage1_singledrug_files/figure-html/fig-4-1.png){#fig-4 width=672}\n:::\n:::\n\n::: {#tbl-4 .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estiamtes plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\ncaz_avi_6 <- read_excel(\"datasets_single/kpcb_caz_avi_powder_4-1.xlsx\")\nfit6 <- drda(tpos ~ ctz_s, data=caz_avi_6, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit6, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 68.88793 </td>\n   <td style=\"text-align:right;\"> 61.14631 </td>\n   <td style=\"text-align:right;\"> 76.62954 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 75.52374 </td>\n   <td style=\"text-align:right;\"> 71.50425 </td>\n   <td style=\"text-align:right;\"> 79.54322 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 82.79876 </td>\n   <td style=\"text-align:right;\"> 79.85671 </td>\n   <td style=\"text-align:right;\"> 85.74080 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 90.77456 </td>\n   <td style=\"text-align:right;\"> 83.70890 </td>\n   <td style=\"text-align:right;\"> 97.84023 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 99.51866 </td>\n   <td style=\"text-align:right;\"> 86.97415 </td>\n   <td style=\"text-align:right;\"> 112.06317 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 105.94237 </td>\n   <td style=\"text-align:right;\"> 88.43755 </td>\n   <td style=\"text-align:right;\"> 123.44720 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n------------------------------------------------------------------------\n\n##### KPC A isolate (MIC 2 mg/L) tested with commercial formulation\n\n-   Experiments with the commercial and analytical powder forms of ceftazidime/avibactam were repeated substituting *Klebsiella pneumoniae* KPC A isolate (ceftazidime/avibactam MIC 2 mg/L).\n\n-   Results of the logistic regression analysis from studies with the commercial formulation demonstrated an EC~50~ 4.14 mg/L (95% CI4.09-4.20) and an EC~90~ 4.78 (95% CI 4.59-4.96) as shown in [@fig-5]. The transitional portion of the dose response curve occurred 1-dilution above the MIC of the isolate (2 mg/L) determined by Etest [@tbl-5].\n\n::: callout-note\nExperiments plotted in [@fig-5] were performed using the commercial CAZ/AVI pharmaceutical formulation for *K. pneumoniae* KPC producing isolate A (MIC 2 mg/L)\n:::\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to ceftazidime concencentrations to estiamted PD parameters\nlibrary (readxl)\nlibrary(drda)\ncaz_avi_7 <- read_excel(\"datasets_single/kpca_caz_avi_com.xlsx\")\nfit7 <- drda(tpos ~ ctz_s, data=caz_avi_7, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit7, xlab = \"CAZ/AVI serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to ceftazidime/avibactam concentrations](Workpackage1_singledrug_files/figure-html/fig-5-1.png){#fig-5 width=672}\n:::\n:::\n\n::: {#tbl-5 .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parametersestiamtes plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\ncaz_avi_7 <- read_excel(\"datasets_single/kpca_caz_avi_com.xlsx\")\nfit7 <- drda(tpos ~ ctz_s, data=caz_avi_7, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit7, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 143.5857 </td>\n   <td style=\"text-align:right;\"> 138.9952 </td>\n   <td style=\"text-align:right;\"> 148.1763 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 154.0912 </td>\n   <td style=\"text-align:right;\"> 151.7888 </td>\n   <td style=\"text-align:right;\"> 156.3936 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 165.3653 </td>\n   <td style=\"text-align:right;\"> 163.4974 </td>\n   <td style=\"text-align:right;\"> 167.2333 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 177.4643 </td>\n   <td style=\"text-align:right;\"> 172.9862 </td>\n   <td style=\"text-align:right;\"> 181.9424 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 190.4485 </td>\n   <td style=\"text-align:right;\"> 183.1369 </td>\n   <td style=\"text-align:right;\"> 197.7601 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 199.8183 </td>\n   <td style=\"text-align:right;\"> 190.5343 </td>\n   <td style=\"text-align:right;\"> 209.1023 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n<br>\n\n#### KPC A isolate (MIC 2 mg/L) tested with analytical powder\n\n-   Similar experiments were performed using the same methodology and **analytical grade powder of ceftazidime-avibactam formulation (fixed 4:1 ratio)** against *Klebsiella pneumoniae* KPC A isolate (ceftazidime/avibactam MIC 2 mg/L).\n\n-   Results of the logistic regression are shown in [@fig-6] and demonstrated an EC~50~ 4.55 mg/L (95% CI4.29-4.83) and an EC~90~ 6.89 (95% CI 5.71-8.08) shown in [@tbl-6]. The transitional portion of the dose response curve was relatively broader and occurred 1-3 dilutions above the MIC of the isolate (2 mg/L) determined by Etest.\n\n::: callout-note\nExperiments reported in [@fig-6] performed using pure powder at a CAZ:AVI ratio of 4:1\n:::\n\n\n::: {.cell}\n\n```{.r .cell-code}\nlibrary (readxl)\nlibrary(drda)\ncaz_avi_8 <- read_excel(\"datasets_single/kpca_caz_avi_powder_4-1.xlsx\")\nfit8 <- drda(tpos ~ ctz_s, data=caz_avi_8, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit8, xlab = \"CAZ/AVI serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to ceftazidime/avibactam concentrations](Workpackage1_singledrug_files/figure-html/fig-6-1.png){#fig-6 width=672}\n:::\n:::\n\n::: {#tbl-6 .cell tbl-cap='Pharmacodynamic relationship of Tpos to ceftazidime/avibactam concentrations'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parametersestiamtes plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\ncaz_avi_8 <- read_excel(\"datasets_single/kpca_caz_avi_powder_4-1.xlsx\")\nfit8 <- drda(tpos ~ ctz_s, data=caz_avi_8, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit8, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 125.7716 </td>\n   <td style=\"text-align:right;\"> 114.3869 </td>\n   <td style=\"text-align:right;\"> 137.1562 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 143.8460 </td>\n   <td style=\"text-align:right;\"> 136.1835 </td>\n   <td style=\"text-align:right;\"> 151.5085 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 164.5179 </td>\n   <td style=\"text-align:right;\"> 158.8981 </td>\n   <td style=\"text-align:right;\"> 170.1377 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 188.1605 </td>\n   <td style=\"text-align:right;\"> 179.1859 </td>\n   <td style=\"text-align:right;\"> 197.1350 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 215.2007 </td>\n   <td style=\"text-align:right;\"> 197.7571 </td>\n   <td style=\"text-align:right;\"> 232.6444 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 235.7798 </td>\n   <td style=\"text-align:right;\"> 202.9734 </td>\n   <td style=\"text-align:right;\"> 268.5861 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n<br>\n\n------------------------------------------------------------------------\n\n### Impact of testing fixed avibactam concentrations on pharmacodynamic estimates\n\n##### KPC A isolate (MIC 2 mg/L)\n\n-   We further explored how the results would change if a single fixed concentration of avibactam (4 mg/L) was used in all tubes. Experiments were performed as described previously using the same method and the analytical-grade powder of ceftazidime-avibactam formulation with at fixed avibactam concentrations against *Klebsiella pneumoniae* KPC B isolate (ceftazidime/avibactam MIC 1 mg/L).\n\n-   Results of the logistic regression are shown in [@fig-7] demonstrated a lower EC~50~ 4.14 mg/L (95% CI 4.09-4.19 ) and an EC~90~ 4.77 (95% CI 4.59-4.96) as shown in [@tbl-7]. The transitional portion of the dose response curve was relatively broader but occurred 1-3 dilutions near the MIC of the isolate (2 mg/L) determined by Etest.\n\n::: callout-note\nExperiments performed in [@fig-7] utilized pure powder with a fixed avibactam concentration of 4 mg/L in all ceftazidime containing bottles.\n:::\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to ceftazidime concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\ncaz_avi_9 <- read_excel(\"datasets_single/kpca_caz_avi_powder_fix4.xlsx\")\nfit9 <- drda(tpos ~ ctz_s, data=caz_avi_9, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit9, xlab = \"CAZ/AVI serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to ceftazidime/avibactam concentrations](Workpackage1_singledrug_files/figure-html/fig-7-1.png){#fig-7 width=672}\n:::\n:::\n\n::: {#tbl-7 .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estiamtes plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\ncaz_avi_9 <- read_excel(\"datasets_single/kpca_caz_avi_powder_fix4.xlsx\")\nfit9 <- drda(tpos ~ ctz_s, data=caz_avi_9, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit9, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 26.02302 </td>\n   <td style=\"text-align:right;\"> 22.05197 </td>\n   <td style=\"text-align:right;\"> 29.99406 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 37.21041 </td>\n   <td style=\"text-align:right;\"> 34.05205 </td>\n   <td style=\"text-align:right;\"> 40.36876 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 53.20729 </td>\n   <td style=\"text-align:right;\"> 50.04995 </td>\n   <td style=\"text-align:right;\"> 56.36463 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 76.08130 </td>\n   <td style=\"text-align:right;\"> 70.56354 </td>\n   <td style=\"text-align:right;\"> 81.59905 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 108.78892 </td>\n   <td style=\"text-align:right;\"> 81.37114 </td>\n   <td style=\"text-align:right;\"> 136.20669 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 138.74444 </td>\n   <td style=\"text-align:right;\"> 47.74622 </td>\n   <td style=\"text-align:right;\"> 229.74266 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n<br>\n\n##### KPC B isolate (MIC 1 mg/L)\n\n-   Similar experiments were repeated with the *Klebsiella pneumoniae* KPC B isolate (ceftazidime/avibactam MIC 1 mg/L).\n\n-   Results of the logistic regression are shown in [@fig-8] and demonstrated a lower EC~50~ 1.28 mg/L (95% CI 1.18-1.38) and an EC~90~ 2.66 (95% CI 1.87-3.44) shown in [@tbl-8]. The transitional portion of the dose response curve was relatively broader but occurred 1-3 dilutions near the MIC of the isolate (1 mg/L) determined by Etest.\n\n::: callout-note\nExperiments shown in [@fig-8] were repeated using pure powder but with a fixed concentration of avibactam at 4 mg/L in all tubes\n:::\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to ceftazidime concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\ncaz_avi_10 <- read_excel(\"datasets_single/kpcb_caz_avi_powder_fix4.xlsx\")\nfit10<- drda(tpos ~ ctz_s, data=caz_avi_10, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit10, xlab = \"CAZ/AVI serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to ceftazidime/avibactam concentrations](Workpackage1_singledrug_files/figure-html/fig-8-1.png){#fig-8 width=672}\n:::\n:::\n\n::: {#tbl-8 .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameters estiamtes plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\ncaz_avi_10 <- read_excel(\"datasets_single/kpcb_caz_avi_powder_fix4.xlsx\")\nfit10 <- drda(tpos ~ ctz, data=caz_avi_10, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit10, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 0.5039331 </td>\n   <td style=\"text-align:right;\"> 0.3607429 </td>\n   <td style=\"text-align:right;\"> 0.6471233 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 0.6443531 </td>\n   <td style=\"text-align:right;\"> 0.5310875 </td>\n   <td style=\"text-align:right;\"> 0.7576186 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 0.8239007 </td>\n   <td style=\"text-align:right;\"> 0.7476945 </td>\n   <td style=\"text-align:right;\"> 0.9001069 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 1.0534790 </td>\n   <td style=\"text-align:right;\"> 0.9303935 </td>\n   <td style=\"text-align:right;\"> 1.1765645 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 1.3470287 </td>\n   <td style=\"text-align:right;\"> 1.0388639 </td>\n   <td style=\"text-align:right;\"> 1.6551936 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 1.5921460 </td>\n   <td style=\"text-align:right;\"> 0.9192446 </td>\n   <td style=\"text-align:right;\"> 2.2650474 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n### Inoculum effects on ceftazidime/avibactam targets with commercial pharmaceutical formulation\n\n#### KPC B isolate (MIC 1 mg/L)\n\nWe examined how the relationship of Tpos vs. ceftazidime/avibactam concentrations changes when tested against a higher inoculum (1x10^7^ CFU/mL). The same methodology as described above was used for testing. As shown in [@fig-3a] and [@tbl-3a] the EC~50~ and EC~90~ were marginally higher when tested at the higher inoculum with a more shallow dose-response relationship.\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to ceftazidime concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\ncaz_avi_5 <- read_excel(\"datasets_single/kpcb_caz_avi_com_hinoc.xlsx\")\nfit5 <- drda(tpos ~ ctz_s, data=caz_avi_5, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit5, xlab = \"CAZ/AVI serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to ceftazidime/avibactam concentrations against a high-inoculum](Workpackage1_singledrug_files/figure-html/fig-3a-1.png){#fig-3a width=672}\n:::\n:::\n\n::: {#tbl-3a .cell tbl-cap='Pharmacodynamic estimates for a high-inoculum'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estimates plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\ncaz_avi_5 <- read_excel(\"datasets_single/kpcb_caz_avi_com_hinoc.xlsx\")\nfit5 <- drda(tpos ~ ctz_s, data=caz_avi_5, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit5, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 82.08148 </td>\n   <td style=\"text-align:right;\"> 71.35951 </td>\n   <td style=\"text-align:right;\"> 92.80344 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 117.28496 </td>\n   <td style=\"text-align:right;\"> 109.48524 </td>\n   <td style=\"text-align:right;\"> 125.08468 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 167.58667 </td>\n   <td style=\"text-align:right;\"> 159.06133 </td>\n   <td style=\"text-align:right;\"> 176.11201 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 239.46201 </td>\n   <td style=\"text-align:right;\"> 222.24533 </td>\n   <td style=\"text-align:right;\"> 256.67869 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 342.16357 </td>\n   <td style=\"text-align:right;\"> 290.42168 </td>\n   <td style=\"text-align:right;\"> 393.90546 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 436.16833 </td>\n   <td style=\"text-align:right;\"> 240.82684 </td>\n   <td style=\"text-align:right;\"> 631.50983 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n### Summary of ceftazidime-avibactam experiments\n\nThese data demonstrate that Tpos is a robust PD endpoint and the relationship of ceftazidime/avibactam concentrations versus Tpos follows classical sigmoidal dose response relationship with a steep transitional portion of the dose response curve that occurs near the MIC of the pathogen. Although ED50/90 estimates were broadly similar if the commercial (pharmaceutical) and analytical powder formulations were tested, used of high-fixed concentrations of avibactam or testing at very high *K. pneumoniae* inocula resulted in broader concentration-effect curves and higher EC50/90 estimates. <br> <br>\n\n------------------------------------------------------------------------\n\n### Meropenem\n\n##### ATCC isolate (MIC 0.03 mg/L)\n\n-   The impact of increasing meropenem concentrations on Tpos observed with the ATCC ESBL producing *Klebsiella pneumoniae* was tested using similar methodology as previously described\n\n-   Analytical powder was used to produce serum concentration\n\n-   As shown in [@fig-9] , Tpos increased as meropenem concentrations surpassed the MIC, with an estimated pharmacodynamic parameters consistent with previous experiments that showed transition in the EC50/EC90 at simulated serum concentrations near the MIC as shown in [@tbl-9].\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to meropenem concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\nmero <- read_excel(\"datasets_single/ATCC_meropenem.xlsx\")\nfit11 <- drda(tpos ~ mero_s, data=mero, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit11, xlab = \"Meropenem serum conc. (mg/L)\", ylab = \"Tpos (hr)\", xlim =c(0,100))\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to meropenem concentrations](Workpackage1_singledrug_files/figure-html/fig-9-1.png){#fig-9 width=672}\n:::\n:::\n\n::: {#tbl-9 .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estimates plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\nmero <- read_excel(\"datasets_single/ATCC_meropenem.xlsx\")\nfit11 <- drda(tpos ~ mero_s, data=mero, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit11, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 1.165027 </td>\n   <td style=\"text-align:right;\"> 1.026833 </td>\n   <td style=\"text-align:right;\"> 1.303220 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 1.460430 </td>\n   <td style=\"text-align:right;\"> 1.351831 </td>\n   <td style=\"text-align:right;\"> 1.569029 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 1.830736 </td>\n   <td style=\"text-align:right;\"> 1.764894 </td>\n   <td style=\"text-align:right;\"> 1.896577 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 2.294935 </td>\n   <td style=\"text-align:right;\"> 2.177266 </td>\n   <td style=\"text-align:right;\"> 2.412605 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 2.876837 </td>\n   <td style=\"text-align:right;\"> 2.586027 </td>\n   <td style=\"text-align:right;\"> 3.167648 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 3.354810 </td>\n   <td style=\"text-align:right;\"> 2.861582 </td>\n   <td style=\"text-align:right;\"> 3.848038 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n##### KPC B isolate (MIC 32 mg/L)\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to meropenem concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\nmero2 <- read_excel(\"datasets_single/KPCB_meropenem.xlsx\")\nfit11 <- drda(tpos ~ mero_s, data=mero2, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit11, xlab = \"Meropenem serum conc. (mg/L)\", ylab = \"Tpos (hr)\", xlim =c(0,100))\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to meropenem concentrations](Workpackage1_singledrug_files/figure-html/fig-9b-1.png){#fig-9b width=672}\n:::\n:::\n\n::: {#tbl-9b .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estimates plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\nmero2 <- read_excel(\"datasets_single/KPCB_meropenem.xlsx\")\nfit11 <- drda(tpos ~ mero_s, data=mero2, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit11, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 39.27741 </td>\n   <td style=\"text-align:right;\"> 38.19835 </td>\n   <td style=\"text-align:right;\"> 40.35648 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 40.68575 </td>\n   <td style=\"text-align:right;\"> 39.82820 </td>\n   <td style=\"text-align:right;\"> 41.54329 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 42.14458 </td>\n   <td style=\"text-align:right;\"> 41.17684 </td>\n   <td style=\"text-align:right;\"> 43.11232 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 43.65572 </td>\n   <td style=\"text-align:right;\"> 42.30388 </td>\n   <td style=\"text-align:right;\"> 45.00756 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 45.22105 </td>\n   <td style=\"text-align:right;\"> 43.33285 </td>\n   <td style=\"text-align:right;\"> 47.10925 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 46.31764 </td>\n   <td style=\"text-align:right;\"> 43.91272 </td>\n   <td style=\"text-align:right;\"> 48.72257 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n<br> A comparison of meropenem activity against the ATCC ESBL-producing reference (MIC 0.03 mg/L) and KPC-carbapenemase producing K. pneumoniae isolates are shown in [@fig-comp]. The meropenem EC~50~ measured by Tpos was 23-fold higher for the KPC-carbapenemase producing isolate versus the the ESBL-producing ATCC isolate. Despite variability in the response was noted for the KPC-B isolate at 20 mg/L and 80 mg/mL concentrations (*experiments are currently being repeated*), the EC50 were nearly identical (indicated by the dotted lines) when corrected for pathogen MIC. These data suggest that it may be possible to substitute *sensitive indicator isolates with low MICs* to predict pharmacodynamic responses of isolates with higher MICs.\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to ceftazidime concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\nmero2 <- read_excel(\"datasets_single/KPCB_meropenem.xlsx\")\nmero <- read_excel(\"datasets_single/ATCC_meropenem.xlsx\")\nfit4a <- drda(tpos ~ mero, mero, mean_function = \"loglogistic4\", max_iter = 1000)\nfit4b <- drda(tpos ~ mero, mero2, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit4a, fit4b, xlab = \"Meropenem conc. (mg/L)\", ylab = \"Tpos\",cex = 0.9,legend = c(\"KP ATCC ESBL\", \"KP KPC_2\"))\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to ceftazidime/avibactam concentrations](Workpackage1_singledrug_files/figure-html/fig-comp-1.png){#fig-comp width=672}\n:::\n:::\n\n\n### Summary of meropenem experiments\n\nSimilar to cefetazidime-avibactam, experiments with meropenem demonstrated that Tpos is a robust PD endpoint and the relationship of meropenem concentrations versus Tpos follows classical sigmoidal dose response relationship with a steep transitional portion of the dose response curve that occurs near the MIC of the pathogen. <br>\n\nA key observation is that the pharmacodynamics were similar when meropenem was tested against a highly-susceptible ATCC isolate (MIC 0.03 mg/L) and and the KPC-producing K.pneumoniae B isolate (MIC 32 mg/L) with at proportional difference in the EC50/90. **Therefore, it may be possible to use highly-susceptible \"indicator\" strains for testing to predict activity against more resistant isolates.** This is important because direct testing of 1 mL inoculum may routinely result in limited antimicrobial activity measured by Tpos (\\<10 hours) as dilutional effects when the serum samples is introduced into the bottle containing a total volume of 42 mL will reduce the actual testing concentrations of the antibiotics below the MIC for highly resistant pathogens. <br> <br> This effect could be counteracted by testing with highly sensitive \"indicator\" isolates based on the expected serum concentrations of the antibiotic.\n\n### Gentamicin\n\n##### KPC A isolate (MIC 2 mg/L)\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to gentamicin concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\ngent1 <- read_excel(\"datasets_single/KPCA_gent.xlsx\")\nfit12 <- drda(tpos ~ gent_s, data=gent1, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit12, xlab = \"Gentamicin serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to gentamicin concentrations](Workpackage1_singledrug_files/figure-html/fig-genta-1.png){#fig-genta width=672}\n:::\n:::\n\n::: {#tbl-genta .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estimates plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\ngent1 <- read_excel(\"datasets_single/KPCA_gent.xlsx\")\nfit12 <- drda(tpos ~ gent_s, data=gent1, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit12, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 56.65250 </td>\n   <td style=\"text-align:right;\"> 53.43037 </td>\n   <td style=\"text-align:right;\"> 59.87462 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 62.53591 </td>\n   <td style=\"text-align:right;\"> 60.25523 </td>\n   <td style=\"text-align:right;\"> 64.81660 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 69.03033 </td>\n   <td style=\"text-align:right;\"> 67.01957 </td>\n   <td style=\"text-align:right;\"> 71.04109 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 76.19920 </td>\n   <td style=\"text-align:right;\"> 73.71019 </td>\n   <td style=\"text-align:right;\"> 78.68821 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 84.11256 </td>\n   <td style=\"text-align:right;\"> 79.42354 </td>\n   <td style=\"text-align:right;\"> 88.80158 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 89.95932 </td>\n   <td style=\"text-align:right;\"> 78.37830 </td>\n   <td style=\"text-align:right;\"> 101.54033 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n##### KPC B isolate (MIC 0.5 mg/L)\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to gentamicin concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\ngent2 <- read_excel(\"datasets_single/KPCB_gent.xlsx\")\nfit13 <- drda(tpos ~ gent_s, data=gent2, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit13, xlab = \"Gentamicin serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to gentamicin concentrations](Workpackage1_singledrug_files/figure-html/fig-gentb-1.png){#fig-gentb width=672}\n:::\n:::\n\n::: {#tbl-gentb .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estimates plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\ngent2 <- read_excel(\"datasets_single/KPCB_gent.xlsx\")\nfit13 <- drda(tpos ~ gent_s, data=gent2, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit13, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 18.56332 </td>\n   <td style=\"text-align:right;\"> 16.93133 </td>\n   <td style=\"text-align:right;\"> 20.19530 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 19.92766 </td>\n   <td style=\"text-align:right;\"> 19.06150 </td>\n   <td style=\"text-align:right;\"> 20.79382 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 21.39227 </td>\n   <td style=\"text-align:right;\"> 20.34817 </td>\n   <td style=\"text-align:right;\"> 22.43636 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 22.96452 </td>\n   <td style=\"text-align:right;\"> 20.81244 </td>\n   <td style=\"text-align:right;\"> 25.11660 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 24.65233 </td>\n   <td style=\"text-align:right;\"> 21.10862 </td>\n   <td style=\"text-align:right;\"> 28.19605 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 25.87062 </td>\n   <td style=\"text-align:right;\"> 20.96263 </td>\n   <td style=\"text-align:right;\"> 30.77861 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n<br>\n\n------------------------------------------------------------------------\n\n### Colistin\n\n#### KPC B isolate (MIC 0.125 mg/L)\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to colistin concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\ncoli1 <- read_excel(\"datasets_single/KPCB_coli.xlsx\")\nfit14 <- drda(tpos ~ coli_s, data=coli1, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit14, xlab = \"Colistin serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to colistin concentrations](Workpackage1_singledrug_files/figure-html/fig-colib-1.png){#fig-colib width=672}\n:::\n:::\n\n::: {#tbl-colib .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estimates plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\ncoli1 <- read_excel(\"datasets_single/KPCB_coli.xlsx\")\nfit14 <- drda(tpos ~ coli_s, data=coli1, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit14, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 3.814341 </td>\n   <td style=\"text-align:right;\"> 3.374386 </td>\n   <td style=\"text-align:right;\"> 4.254296 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 4.696574 </td>\n   <td style=\"text-align:right;\"> 4.395993 </td>\n   <td style=\"text-align:right;\"> 4.997155 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 5.782863 </td>\n   <td style=\"text-align:right;\"> 5.463324 </td>\n   <td style=\"text-align:right;\"> 6.102402 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 7.120404 </td>\n   <td style=\"text-align:right;\"> 6.500514 </td>\n   <td style=\"text-align:right;\"> 7.740293 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 8.767309 </td>\n   <td style=\"text-align:right;\"> 7.696486 </td>\n   <td style=\"text-align:right;\"> 9.838132 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 10.100091 </td>\n   <td style=\"text-align:right;\"> 8.130500 </td>\n   <td style=\"text-align:right;\"> 12.069682 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n------------------------------------------------------------------------\n\n### Meropenem-vaborbactam\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to meropenem-vaborbactam concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\nvabo1 <- read_excel(\"datasets_single/KPCB_vabo.xlsx\")\nfit14 <- drda(tpos ~ vabo_s, data=vabo1, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit14, xlab = \"Meropenem-vabobactam serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to meropenem-vaborbactam concentrations](Workpackage1_singledrug_files/figure-html/fig-vabob-1.png){#fig-vabob width=672}\n:::\n:::\n\n::: {#tbl-vabob .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estimates plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\nvabo1 <- read_excel(\"datasets_single/KPCB_vabo.xlsx\")\nfit14 <- drda(tpos ~ vabo_s, data=vabo1, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit14, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 5.391292 </td>\n   <td style=\"text-align:right;\"> 4.092373 </td>\n   <td style=\"text-align:right;\"> 6.690211 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 7.797856 </td>\n   <td style=\"text-align:right;\"> 6.671079 </td>\n   <td style=\"text-align:right;\"> 8.924633 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 11.278661 </td>\n   <td style=\"text-align:right;\"> 10.098053 </td>\n   <td style=\"text-align:right;\"> 12.459269 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 16.313228 </td>\n   <td style=\"text-align:right;\"> 13.817427 </td>\n   <td style=\"text-align:right;\"> 18.809029 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 23.595123 </td>\n   <td style=\"text-align:right;\"> 18.006802 </td>\n   <td style=\"text-align:right;\"> 29.183445 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 30.327549 </td>\n   <td style=\"text-align:right;\"> 19.089870 </td>\n   <td style=\"text-align:right;\"> 41.565227 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n------------------------------------------------------------------------\n\n### Tigecycline\n\n#### K. pneumonia KPC-A (MIC 0.75 mg/L)\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to tigecycline concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\ntig1 <- read_excel(\"datasets_single/kpca_tig.xlsx\")\nfit15 <- drda(tpos ~ tig_s, data=tig1, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit15, xlab = \"Tigecycline serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to tigecycline concentrations](Workpackage1_singledrug_files/figure-html/fig-tiga-1.png){#fig-tiga width=672}\n:::\n:::\n\n::: {#tbl-tiga .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estimates plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\ntig1 <- read_excel(\"datasets_single/kpca_tig.xlsx\")\nfit15 <- drda(tpos ~ tig_s, data=tig1, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit15, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 26.21193 </td>\n   <td style=\"text-align:right;\"> 22.64088 </td>\n   <td style=\"text-align:right;\"> 29.78298 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 33.33312 </td>\n   <td style=\"text-align:right;\"> 30.73822 </td>\n   <td style=\"text-align:right;\"> 35.92801 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 42.38896 </td>\n   <td style=\"text-align:right;\"> 40.56986 </td>\n   <td style=\"text-align:right;\"> 44.20806 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 53.90507 </td>\n   <td style=\"text-align:right;\"> 50.72689 </td>\n   <td style=\"text-align:right;\"> 57.08325 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 68.54984 </td>\n   <td style=\"text-align:right;\"> 60.64442 </td>\n   <td style=\"text-align:right;\"> 76.45527 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 80.72308 </td>\n   <td style=\"text-align:right;\"> 56.72937 </td>\n   <td style=\"text-align:right;\"> 104.71680 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n#### K. pneumonia KPC-B (MIC 0.38 mg/L)\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to tigecycline concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\ntig2 <- read_excel(\"datasets_single/kpcb_tig.xlsx\")\nfit16 <- drda(tpos ~ tig_s, data=tig2, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit16, xlab = \"Tigecycline serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to tigecycline concentrations](Workpackage1_singledrug_files/figure-html/fig-tigb-1.png){#fig-tigb width=672}\n:::\n:::\n\n::: {#tbl-tigb .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estimates plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\ntig2 <- read_excel(\"datasets_single/kpca_tig.xlsx\")\nfit16 <- drda(tpos ~ tig_s, data=tig2, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit16, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 26.21193 </td>\n   <td style=\"text-align:right;\"> 22.64088 </td>\n   <td style=\"text-align:right;\"> 29.78298 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 33.33312 </td>\n   <td style=\"text-align:right;\"> 30.73822 </td>\n   <td style=\"text-align:right;\"> 35.92801 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 42.38896 </td>\n   <td style=\"text-align:right;\"> 40.56986 </td>\n   <td style=\"text-align:right;\"> 44.20806 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 53.90507 </td>\n   <td style=\"text-align:right;\"> 50.72689 </td>\n   <td style=\"text-align:right;\"> 57.08325 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 68.54984 </td>\n   <td style=\"text-align:right;\"> 60.64442 </td>\n   <td style=\"text-align:right;\"> 76.45527 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 80.72308 </td>\n   <td style=\"text-align:right;\"> 56.72937 </td>\n   <td style=\"text-align:right;\"> 104.71680 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n\n\n### Ceftazidime\n\n#### Klebsiella pneumoniae (KP_DAM; ceftazidime MIC 4 mg/L)\n\n\n::: {.cell}\n\n```{.r .cell-code}\n## a four-parameter logistic regression model is fit to ceftazidime concentrations to estimated PD parameters\nlibrary (readxl)\nlibrary(drda)\nceftaz1 <- read_excel(\"datasets_single/kp_dam_ceftaz.xlsx\")\nfit17 <- drda(tpos ~ ctz_s, data=ceftaz1, mean_function = \"loglogistic4\", max_iter = 1000)\nplot(fit17, xlab = \"Ceftazidime serum conc. (mg/L)\", ylab = \"Tpos (hr)\")\n```\n\n::: {.cell-output-display}\n![Pharmacodynamic relationship of Tpos to ceftazidime concentrations](Workpackage1_singledrug_files/figure-html/fig-ceftaz_dam-1.png){#fig-ceftaz_dam width=672}\n:::\n:::\n\n::: {#tbl-ceftaz_dam .cell tbl-cap='Pharmacodynamic estimates'}\n\n```{.r .cell-code}\n## Analysis is repeated to produce a table reporting estimated EC10-EC95 parameter estimates plus 95% CI \nlibrary (readxl)\nlibrary(drda)\nlibrary(broom)\nlibrary(kableExtra)\nceftaz1 <- read_excel(\"datasets_single/kp_dam_ceftaz.xlsx\")\nfit17 <- drda(tpos ~ ctz_s, data=ceftaz1, mean_function = \"loglogistic4\", max_iter = 1000)\ned<-effective_dose(fit17, y = c(0.10,0.25,0.50,0.75,0.90,0.95))\nkbl(ed)%>%\nkable_paper(\"hover\", full_width = F, position = \"left\")\n```\n\n::: {.cell-output-display}\n`````{=html}\n<table class=\" lightable-paper lightable-hover\" style='font-family: \"Arial Narrow\", arial, helvetica, sans-serif; width: auto !important; '>\n <thead>\n  <tr>\n   <th style=\"text-align:left;\">   </th>\n   <th style=\"text-align:right;\"> Estimate </th>\n   <th style=\"text-align:right;\"> Lower .95 </th>\n   <th style=\"text-align:right;\"> Upper .95 </th>\n  </tr>\n </thead>\n<tbody>\n  <tr>\n   <td style=\"text-align:left;\"> 0.1 </td>\n   <td style=\"text-align:right;\"> 107.0276 </td>\n   <td style=\"text-align:right;\"> 78.27442 </td>\n   <td style=\"text-align:right;\"> 135.7809 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.25 </td>\n   <td style=\"text-align:right;\"> 136.4083 </td>\n   <td style=\"text-align:right;\"> 116.29285 </td>\n   <td style=\"text-align:right;\"> 156.5238 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.5 </td>\n   <td style=\"text-align:right;\"> 173.8544 </td>\n   <td style=\"text-align:right;\"> 165.49765 </td>\n   <td style=\"text-align:right;\"> 182.2112 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.75 </td>\n   <td style=\"text-align:right;\"> 221.5801 </td>\n   <td style=\"text-align:right;\"> 196.00814 </td>\n   <td style=\"text-align:right;\"> 247.1520 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.9 </td>\n   <td style=\"text-align:right;\"> 282.4071 </td>\n   <td style=\"text-align:right;\"> 224.19394 </td>\n   <td style=\"text-align:right;\"> 340.6202 </td>\n  </tr>\n  <tr>\n   <td style=\"text-align:left;\"> 0.95 </td>\n   <td style=\"text-align:right;\"> 333.0621 </td>\n   <td style=\"text-align:right;\"> 230.10196 </td>\n   <td style=\"text-align:right;\"> 436.0223 </td>\n  </tr>\n</tbody>\n</table>\n\n`````\n:::\n:::\n",
    "supporting": [
      "Workpackage1_singledrug_files"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {
      "include-in-header": [
        "<script src=\"site_libs/kePrint-0.0.1/kePrint.js\"></script>\n<link href=\"site_libs/lightable-0.0.1/lightable.css\" rel=\"stylesheet\" />\n"
      ]
    },
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}